Mi­rati and MD An­der­son team up on KRAS; Sanofi inks deal with a Har­vard spin­out for oral bi­o­log­ics

Mi­rati, the oth­er KRAS-fo­cused biotech, is get­ting some ex­tra am­mo as it looks to leapfrog Am­gen in the hunt for the first, most ef­fec­tive and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.